JPMORGAN CHASE & CO - CIDARA THERAPEUTICS INC ownership

CIDARA THERAPEUTICS INC's ticker is CDTX and the CUSIP is 171757107. A total of 47 filers reported holding CIDARA THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
JPMORGAN CHASE & CO ownership history of CIDARA THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$315
-27.1%
334
-12.6%
0.00%
Q2 2023$432382
+213.1%
0.00%
Q1 2023$0122
-41.9%
0.00%
Q4 2022$0210
-13.6%
0.00%
Q3 2022$0243
+15.7%
0.00%
Q2 2022$0210
+72.1%
0.00%
Q1 2022$0
-100.0%
122
-98.8%
0.00%
Q4 2021$13,000
+160.0%
10,217
+299.3%
0.00%
Q3 2021$5,000
-96.1%
2,559
-96.0%
0.00%
Q2 2021$128,000
-52.4%
63,682
-37.0%
0.00%
Q1 2021$269,000
+40.8%
101,057
+5.8%
0.00%
Q4 2020$191,000
+402.6%
95,481
+627.1%
0.00%
Q3 2020$38,000
-7.3%
13,132
+16.9%
0.00%
Q2 2020$41,000
+1950.0%
11,235
+1115.9%
0.00%
Q3 2019$2,000
-97.3%
924
-98.1%
0.00%
Q2 2019$75,000
-49.0%
47,860
-13.7%
0.00%
Q1 2019$147,000
-51.0%
55,441
-56.6%
0.00%
Q4 2018$300,000
-54.3%
127,848
-14.2%
0.00%
Q3 2018$656,000
+59.6%
149,050
+88.5%
0.00%
Q2 2018$411,000
+48.4%
79,052
+14.3%
0.00%
Q1 2018$277,000
+9.9%
69,172
+87.0%
0.00%
Q4 2017$252,000
-23.2%
36,991
-10.4%
0.00%
Q3 2017$328,000
+88.5%
41,266
+77.4%
0.00%
Q2 2017$174,000
-13.0%
23,265
-9.3%
0.00%
Q1 2017$200,000
+316.7%
25,639
+455.6%
0.00%
Q4 2016$48,000
-20.0%
4,615
-12.4%
0.00%
Q3 2016$60,000
-30.2%
5,267
-36.7%
0.00%
Q2 2016$86,000
+8500.0%
8,321
+7396.4%
0.00%
Q1 2016$1,0001110.00%
Other shareholders
CIDARA THERAPEUTICS INC shareholders Q2 2022
NameSharesValueWeighting ↓
ALETHEA CAPITAL MANAGEMENT, LLC 1,627,670$1,533,5911.88%
5AM Venture Management, LLC 1,134,511$1,068,9360.31%
Nantahala Capital Management 2,538,406$2,391,6860.20%
BVF INC/IL 6,861,127$6,464,5540.17%
Monashee Investment Management LLC 369,099$347,7650.14%
West Family Investments, Inc. 368,910$347,5870.12%
JEPPSON WEALTH MANAGEMENT, LLC 137,560$129,6090.06%
XTX Topco Ltd 202,758$191,0390.03%
GSA CAPITAL PARTNERS LLP 136,974$1290.01%
Callan Capital, LLC 103,462$97,4820.01%
View complete list of CIDARA THERAPEUTICS INC shareholders